Bastide Le Confort Médical Toekomstige groei
Future criteriumcontroles 5/6
Bastide Le Confort Médical zal naar verwachting groeien in winst en omzet met respectievelijk 34.1% en 6.6% per jaar. De winst per aandeel zal naar verwachting groeien met 34.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 24.2% zijn.
Belangrijke informatie
34.1%
Groei van de winst
34.4%
Groei van de winst per aandeel
| Healthcare winstgroei | 24.9% |
| Inkomstengroei | 6.6% |
| Toekomstig rendement op eigen vermogen | 24.2% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 15 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Bastide Le Confort Médical's (EPA:BLC) Soft Earnings Don't Show The Whole Picture
Nov 13
Bastide Le Confort Médical SA (EPA:BLC) Just Reported, And Analysts Assigned A €28.17 Price Target
Oct 26We Like These Underlying Return On Capital Trends At Bastide Le Confort Médical (EPA:BLC)
Jun 14Bastide Le Confort Médical (EPA:BLC) Has A Somewhat Strained Balance Sheet
May 27Why Investors Shouldn't Be Surprised By Bastide Le Confort Médical SA's (EPA:BLC) 28% Share Price Surge
May 12Is Now An Opportune Moment To Examine Bastide Le Confort Médical SA (EPA:BLC)?
Apr 27Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality
Apr 06Benign Growth For Bastide Le Confort Médical SA (EPA:BLC) Underpins Stock's 26% Plummet
Mar 28Positive Sentiment Still Eludes Bastide Le Confort Médical SA (EPA:BLC) Following 28% Share Price Slump
Feb 08The Return Trends At Bastide Le Confort Médical (EPA:BLC) Look Promising
Nov 18What Is Bastide Le Confort Médical SA's (EPA:BLC) Share Price Doing?
May 17Bastide Le Confort Médical (EPA:BLC) Is Doing The Right Things To Multiply Its Share Price
Jan 27Is Bastide Le Confort Médical SA (EPA:BLC) Potentially Undervalued?
Nov 22Bastide Le Confort Médical (EPA:BLC) Is Reinvesting At Lower Rates Of Return
Sep 21Is It Time To Consider Buying Bastide Le Confort Médical SA (EPA:BLC)?
Jul 28When Should You Buy Bastide Le Confort Médical SA (EPA:BLC)?
Mar 18Be Wary Of Bastide Le Confort Médical (EPA:BLC) And Its Returns On Capital
May 16Here's Why Bastide Le Confort Médical (EPA:BLC) Has A Meaningful Debt Burden
Apr 30We Think Bastide Le Confort Médical's (EPA:BLC) Profit Is Only A Baseline For What They Can Achieve
Apr 07Should You Think About Buying Bastide Le Confort Médical SA (EPA:BLC) Now?
Mar 10Is Bastide Le Confort Médical SA's (EPA:BLC) 16% ROE Better Than Average?
Feb 21Bastide Le Confort Médical SA's (EPA:BLC) Intrinsic Value Is Potentially 33% Above Its Share Price
Feb 07
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2027 | 645 | 26 | 47 | 108 | 2 |
| 6/30/2026 | 606 | 24 | 37 | 98 | 2 |
| 6/30/2025 | 568 | 19 | 30 | 89 | 2 |
| 6/30/2024 | 530 | 7 | 37 | 93 | N/A |
| 3/31/2024 | 527 | 7 | 36 | 90 | N/A |
| 12/31/2023 | 523 | 6 | 34 | 88 | N/A |
| 9/30/2023 | 516 | 11 | 43 | 97 | N/A |
| 6/30/2023 | 508 | 16 | 52 | 106 | N/A |
| 12/31/2022 | 495 | 18 | 15 | 68 | N/A |
| 9/30/2022 | 482 | 16 | 9 | 63 | N/A |
| 6/30/2022 | 468 | 14 | 4 | 57 | N/A |
| 12/31/2021 | 446 | 13 | 33 | 81 | N/A |
| 9/30/2021 | 445 | 13 | 31 | 78 | N/A |
| 6/30/2021 | 444 | 13 | 28 | 74 | N/A |
| 3/31/2021 | 436 | 12 | 19 | 65 | N/A |
| 12/31/2020 | 428 | 11 | 11 | 55 | N/A |
| 9/30/2020 | 405 | 11 | 9 | 51 | N/A |
| 6/30/2020 | 383 | 12 | 8 | 47 | N/A |
| 3/31/2020 | 365 | 9 | 16 | 55 | N/A |
| 12/31/2019 | 347 | 7 | 25 | 62 | N/A |
| 9/30/2019 | 341 | 6 | 26 | 62 | N/A |
| 6/30/2019 | 336 | 6 | 27 | 61 | N/A |
| 3/31/2019 | 328 | 7 | 22 | 58 | N/A |
| 12/31/2018 | 321 | 9 | 18 | 56 | N/A |
| 9/30/2018 | 305 | 8 | 15 | 53 | N/A |
| 6/30/2018 | 289 | 7 | 12 | 50 | N/A |
| 3/31/2018 | 267 | 6 | N/A | 43 | N/A |
| 12/31/2017 | 245 | 5 | N/A | 35 | N/A |
| 9/30/2017 | 232 | 5 | N/A | 31 | N/A |
| 6/30/2017 | 218 | 5 | N/A | 26 | N/A |
| 3/31/2017 | 211 | 6 | N/A | 26 | N/A |
| 12/31/2016 | 203 | 7 | N/A | 25 | N/A |
| 9/30/2016 | 198 | 7 | N/A | 28 | N/A |
| 6/30/2016 | 192 | 7 | N/A | 32 | N/A |
| 3/31/2016 | 187 | 7 | N/A | 32 | N/A |
| 12/31/2015 | 182 | 7 | N/A | 32 | N/A |
| 9/30/2015 | 177 | 7 | N/A | 28 | N/A |
| 6/30/2015 | 171 | 7 | N/A | 24 | N/A |
| 3/31/2015 | 166 | 7 | N/A | N/A | N/A |
| 12/31/2014 | 160 | 6 | N/A | 19 | N/A |
| 9/30/2014 | 156 | 6 | N/A | 19 | N/A |
| 6/30/2014 | 152 | 5 | N/A | 18 | N/A |
| 3/31/2014 | 148 | 5 | N/A | N/A | N/A |
| 12/31/2013 | 143 | 5 | N/A | 19 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei BLC ( 34.1% per jaar) ligt boven de spaarquote ( 1.4% ).
Winst versus markt: De winst van BLC ( 34.1% per jaar) zal naar verwachting sneller groeien dan de French markt ( 12.4% per jaar).
Hoge groeiwinsten: De winst van BLC zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van BLC ( 6.6% per jaar) zal naar verwachting sneller groeien dan de markt French ( 5.6% per jaar).
Hoge groei-inkomsten: De omzet van BLC ( 6.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen BLC zal naar verwachting over 3 jaar hoog zijn ( 24.2 %)